Idiopathic Pulmonary Fibrosis Video Perspectives

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

2:06Ganesh Raghu, MD

What progress has recently been made in the treatment of IPF?

1:59Ganesh Raghu, MD

What is your treatment approach for patients at high risk for poor outcomes?

2:45Ganesh Raghu, MD

What does recent research suggest about the use of combination therapy vs. monotherapy?

0:50Ganesh Raghu, MD

What are the most promising treatments in the pipeline?

2:46Ganesh Raghu, MD

What are some of the biggest unanswered questions in IPF?

1:15Ganesh Raghu, MD

What is your advice to clinicians?

Ganesh Raghu, MD, is the director of the Center for Interstitial Lung Disease, professor of medicine and adjunct professor of laboratory medicine at the University of Washington School of Medicine.

In this ad hoc video, Raghu discusses:

advances in idiopathic pulmonary fibrosis, including the importance of a precise diagnosis approach utilizing evidence based clinical practice guidelines and the appropriate use of antifibrotic drugs;
the importance of a multidisciplinary treatment approach for patients for accurate diagnosis;
the use of combination therapy in patients manifesting signs of pulmonary hypertension;
new treatments in the pipeline;
unanswered questions in the field of idiopathic pulmonary fibrosis; and
his advice to clinicians.